BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2109522)

  • 1. Assessment of a fixed-dosage combination of atenolol and chlorthalidone (Tenoretic) in hypertensive Nigerians.
    Salako LA; Falase AO; Aderounmu AF; Walker O
    Afr J Med Med Sci; 1990 Mar; 19(1):57-61. PubMed ID: 2109522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Half-strength atenolol-chlorthalidone combination (tenoretic mite) in the treatment of elderly hypertensive patients.
    Fogari R; Zoppi A
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):386-93. PubMed ID: 6469428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atenolol and chlorthalidone therapy for hypertension: a double-blind comparison.
    Curry RC; Schwartz KM; Urban PL
    South Med J; 1988 Nov; 81(11):1401-6, 1411. PubMed ID: 3055324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effectiveness of low-dose chlorthalidone (6.25 mg) + atenolol combination in stage I hypertensive patients: a multicenter, randomized, controlled study.
    Pareek A; Karnik N; Salagre SB; Zawar SD; Joglekar VK; Chandurkar N; Naik GS
    Curr Med Res Opin; 2008 Jun; 24(6):1771-9. PubMed ID: 18479589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the antihypertensive effect of atenolol in fixed or free combination with chlorthalidone.
    Nissinen A; Tuomilehto J
    Pharmatherapeutica; 1980; 2(7):462-8. PubMed ID: 7010382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive therapy with diuretics and beta-blockers at fixed dosage: comparison between the combinations labetalol plus chlorthalidone and atenolol plus chlorthalidone.
    Roja M; Cumetti C; Vergani A; Montanari C; De Cristofaro A
    Drugs Exp Clin Res; 1985; 11(12):851-60. PubMed ID: 2873012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmarketing survey of the effects of an atenolol/chlorthalidone combination in the treatment of hypertension.
    Maxwell MH; Garrett BN; Saunders E; Schnaper H
    Clin Ther; 1987; 9(4):380-9. PubMed ID: 3607820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose atenolol-chlorthalidone combination for treatment of mild hypertension.
    Leonetti G; Pasotti C; Capra A
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):43-7. PubMed ID: 3514487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A comparative study of atenolol (Tenormin) and the combined preparation atenolol/chlorthalidone (Tenoretic Mite) in essential hypertension. A randomized double-blind study from general practice].
    Pilgaard S; Palmelund VO; Svendsen TL
    Ugeskr Laeger; 1990 Apr; 152(15):1083-6. PubMed ID: 2184556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of hypertensive hyperuricemic patients with a new beta blocker-diuretic combination].
    Brandstetter G; Hoffmann H
    Wien Klin Wochenschr; 1984 Sep; 96(18):696-9. PubMed ID: 6240831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atenolol and chlorthalidone administered alone and in combination for essential hypertension.
    Boike SC; Durley Y; Cubberley RB
    Clin Pharm; 1982; 1(5):449-53. PubMed ID: 6764166
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of essential arterial hypertension with the fixed-dose combination of atenolol and chlorthalidone (Tenoretic) in a single daily administration].
    Lavezzaro GC; Eandi M; Minelli M; Gastaldo D; Noussan P; Angelino PF; Buraglio M
    Minerva Cardioangiol; 1982; 30(7-8):359-66. PubMed ID: 7133425
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of a multicenter trial of antihypertensive treatment with atenolol, alone or in combination with chlorthalidone, of patients with mild, moderate and severe hypertension].
    Novo S; Giannola A; Immordino R; Strano A
    Cardiologia; 1987 Jan; 32(1):33-49. PubMed ID: 3555793
    [No Abstract]   [Full Text] [Related]  

  • 14. Antihypertensive activity of a fixed combination of oxprenolol and chlorthalidone in mild to moderate arterial hypertension.
    Motolese M; Agabiti-Rosei E; Carotti A; Innocenti P; Montervino C; Solinas E; Toso M; Muiesan G
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):332-7. PubMed ID: 7409934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control.
    Holzgreve H; Nakov R; Beck K; Janka HU
    Am J Hypertens; 2003 May; 16(5 Pt 1):381-6. PubMed ID: 12745200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of long-term antihypertensive therapy with tenoretic--a combined long-acting drug].
    Ivashkin VT; Grigor'ev IuV; Sinopal'nikov AI
    Klin Med (Mosk); 1990 Jul; 68(7):70-2. PubMed ID: 2232654
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of the antihypertensive effectiveness of the atenolol-chlorthalidone combination (Tenoretic)].
    Malini PL; Costa FV; Cavallini C; Marata AM; Ambrosioni E; Magnani B
    Minerva Cardioangiol; 1982; 30(7-8):375-80. PubMed ID: 7133427
    [No Abstract]   [Full Text] [Related]  

  • 18. Once daily combination therapy for hypertension.
    Asbury MJ; Wells FO; Barker NP
    Practitioner; 1980 Dec; 224(1350):1306-9. PubMed ID: 7012818
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic treatment with tibalosine in essential hypertension.
    Staessen J; Fagard R; Fiocchi R; Lijnen P; M'Buyamba-Kabangu JR; Amery A
    Arch Int Pharmacodyn Ther; 1986 Jan; 279(1):162-76. PubMed ID: 3516092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of different fixed antihypertensive combination drugs: a double-blind, placebo-controlled parallel group study.
    de Leeuw PW; Notter T; Zilles P
    J Hypertens; 1997 Jan; 15(1):87-91. PubMed ID: 9050975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.